Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fenaux

Showing results (191-200 of 320) with videos related to

Pageof 32
Sort By:
Leukemia|May 1, 1995
Prognostic value of c-mpl expression in myelodysplastic syndromesD Bouscary, C Preudhomme, V Ribrag, et al.
Leukemia|December 1, 1993
Autologous bone marrow transplantation with marrow purged by mafosfamide in seven patients with myelodysplastic syndromes in transformation (AML-MDS): a pilot studyJ P Laporte, F Isnard, S Lesage, et al.
Blood|November 1, 1992
All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 casesP Fenaux, S Castaigne, H Dombret, et al.
European Journal of Haematology|April 1, 1988
Refractory anaemia according to the FAB classification: a report on 69 casesP Fenaux, M H Estienne, P Lepelley, et al.
Blood|October 1, 1993
Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cellsL Delva, M Cornic, N Balitrand, et al.
Blood|January 15, 1998
Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletionY Sterkers, C Preudhomme, J L Laï, et al.
Leukemia & Lymphoma|July 1, 1995
Good predictive value of combined cytogenetic and molecular follow up in chronic myelogenous leukemia after non T-cell depleted allogeneic bone marrow transplantation: a report on 38 consecutive casesC Preudhomme, E Wattel, J L Lai, et al.
Leukemia & Lymphoma|February 1, 1995
Treatment of newly diagnosed acute promyelocytic leukemia (APL) by all transretinoic acid (ATRA) combined with chemotherapy: The European experience. European APL GroupP Fenaux, C Chastang, C Chomienne, et al.
Oncogene|December 17, 2008
ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemiaJ Grosjean-Raillard, M Tailler, L Adès, et al.
Blood|November 15, 1991
Elevated serum levels of soluble interleukin-2 receptor: a marker of disease activity in the hypereosinophilic syndromeL Prin, J Plumas, V Gruart, et al.
Pageof 32

Showing results (191-200 of 320) with videos related to

Sort By:
Pageof 32
Leukemia|May 1, 1995
Prognostic value of c-mpl expression in myelodysplastic syndromesD Bouscary, C Preudhomme, V Ribrag, et al.
Leukemia|December 1, 1993
Autologous bone marrow transplantation with marrow purged by mafosfamide in seven patients with myelodysplastic syndromes in transformation (AML-MDS): a pilot studyJ P Laporte, F Isnard, S Lesage, et al.
Blood|November 1, 1992
All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 casesP Fenaux, S Castaigne, H Dombret, et al.
European Journal of Haematology|April 1, 1988
Refractory anaemia according to the FAB classification: a report on 69 casesP Fenaux, M H Estienne, P Lepelley, et al.
Blood|October 1, 1993
Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cellsL Delva, M Cornic, N Balitrand, et al.
Blood|January 15, 1998
Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletionY Sterkers, C Preudhomme, J L Laï, et al.
Leukemia & Lymphoma|July 1, 1995
Good predictive value of combined cytogenetic and molecular follow up in chronic myelogenous leukemia after non T-cell depleted allogeneic bone marrow transplantation: a report on 38 consecutive casesC Preudhomme, E Wattel, J L Lai, et al.
Leukemia & Lymphoma|February 1, 1995
Treatment of newly diagnosed acute promyelocytic leukemia (APL) by all transretinoic acid (ATRA) combined with chemotherapy: The European experience. European APL GroupP Fenaux, C Chastang, C Chomienne, et al.
Oncogene|December 17, 2008
ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemiaJ Grosjean-Raillard, M Tailler, L Adès, et al.
Blood|November 15, 1991
Elevated serum levels of soluble interleukin-2 receptor: a marker of disease activity in the hypereosinophilic syndromeL Prin, J Plumas, V Gruart, et al.
Pageof 32